Willow Biosciences (TSE: WLLO- OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive with news the company has announced plans to commercially launch their proprietary yeast strain for the production of THC for Cannabis 2.0.
Peters talks about the research that has gone into this and that it’s odourless and flavourless attributes will make a strong core ingredient to produce products with. Peters also shares the timeline for this product to be available.